CHOLINERGIC MEDIATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF CLOZAPINE

被引：52

作者：

NIELSEN, EB

机构：

来源：

PSYCHOPHARMACOLOGY | 1988年 / 94卷 / 01期

关键词：

D O I：

10.1007/BF00735891

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：115 / 118

页数：4

共 21 条

[1] SPECIFIC BINDING OF H-3 SCH 23390 TO DOPAMINE D1 RECEPTORS INVIVO [J].

ANDERSEN, PH ;

GRONVALD, FC .

LIFE SCIENCES, 1986, 38 (16) :1507-1514

[2]

BROWNE RG, 1982, DRUG DISCRIMINATION, P241

[3]

Colpaert F. C., 1982, DRUG DISCRIMINATION

[4]

EICHENBERGER E, 1984, ARZNEIMITTEL-FORSCH, V34-1, P110

[5] GUANINE-NUCLEOTIDE REGULATION OF AGONIST BINDING TO MUSCARINIC CHOLINERGIC RECEPTORS - RELATION TO EFFICACY OF AGONISTS FOR STIMULATION OF PHOSPHOINOSITIDE BREAKDOWN AND CA-2+ MOBILIZATION [J].

EVANS, T ;

HEPLER, JR ;

MASTERS, SB ;

BROWN, JH ;

HARDEN, TK .

BIOCHEMICAL JOURNAL, 1985, 232 (03) :751-757

[6] EXTRAPYRAMIDAL REACTIONS AND AMINE METABOLITES IN CEREBROSPINAL-FLUID DURING HALOPERIDOL AND CLOZAPINE TREATMENT OF SCHIZOPHRENIC-PATIENTS [J].

GERLACH, J ;

THORSEN, K ;

FOG, R .

PSYCHOPHARMACOLOGIA, 1975, 40 (04) :341-350

[7]

GOAS JA, 1978, PHARMACOL BIOCHEM BE, V8, P235

[8] 5-HT2 RECEPTOR BLOCKADE TO STUDY SEROTONIN-INDUCED PATHOLOGY [J].

JANSSEN, PAJ .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1983, 4 (05) :198-206

[9]

KUBENA RK, 1969, PSYCHOPHARMACOLOGIA, V15, P196

[10]

LUTHIN GR, 1985, J PHARMACOL EXP THER, V234, P37

← 1 2 3 →